EMEA-000852-PIP01-10-M01

Key facts

Active substance	Pollen from Betula pendula (33%), Corylus avellana (33%) and Alnus glutinosa (33%)
Therapeutic area	Pneumology-allergology
Decision number	P/0277/2015
PIP number	EMEA-000852-PIP01-10-M01
Pharmaceutical form(s)	Oromucosal solution
Condition(s) / indication(s)	Treatment of allergic rhinitis Treatment of rhino-conjuctivitis
Route(s) of administration	Sublingual use
Contact for public enquiries	ALK-Abelló A/S Denmark Tel. +45 4574 8079 E-mail: alkmrp@alk.net
Decision type	PM: decision on the application for modification of an agreed PIP

Decision

List item

P/0277/2015: EMA decision of 27 November 2015 on the acceptance of a modification of an agreed paediatric investigation plan for pollen from betula pendula (33%), corylus avellana (33%) and alnus glutinosa (33%), (EMEA-000852-PIP01-10-M01) (PDF/103.95 KB)

Adopted

First published: 07/01/2016
Last updated: 07/01/2016
EMA/732714/2015

Related content

List item

Pollen from Betula pendula (33%), Corylus avellana (33%) and Alnus glutinosa (33%) - Notification of discontinuation of a paediatric development which is covered by an agreed PIP Decision (PDF/120.21 KB) (new)

First published: 05/01/2021
EMEA-000852-PIP01-10-M01

How useful was this page?

Add your rating

★ ★ ★ ★ ★